Anand Desai, Managing Director of Anupam Rasayan, commented, “Despite the challenges brought by the pandemic, we are pleased to have had such a solid start to the new financial year. As a result of the company's timely debt repayment, the company's balance sheet has become leaner and more in line with the company's scale of operations. We have clearly defined strategic objectives of increasing capital efficiency, capturing profitable growth and generating positive cash flow which will lead to significant increase in RoE and RoCE; this all is reflected in our superior EBITDA margins of 27%, an increase of 300 basis points both Q-o-Q and Y-o-Y. To stay ahead of the curve, keep abreast with the advancements in technology, and stride ahead of the competition, we continue to increase our investments in research and development, especially in light of increasing inquiries received from major MNCs recently exhibiting promising market potential.”